Regulation & law · 20/11/20261 min read
What Should Tenax Therapeutics, Inc. Investors Know After 89.77% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline
Summary
Lawsuit alleges Tenax Therapeutics, Inc. made misleading statements to investors from November 13, 2023 to August 7, 2026; lead plaintiff motions are due December 28, 2026 LOS ANGELES, Nov. 20, 2026 — The Law Offices of Frank R. Cruz today announced a class action lawsuit...